Optimata

Company Overview

Snapshot

Founded in January 2000 by Zvia Agur, Optimata operated with 1–10 employees. The company raised a total of $4 million across three funding rounds. Optimata ceased operations in December 2021.

Business overview

Optimata is a Health Tech & Life Sciences company focused on personalized oncology treatment. The company develops solutions that integrate high-level, multiscale modeling with large databases to predict oncology patient prognoses and drug therapy benefits, thereby improving treatment decisions. Its core products include PrediCare, a decision support tool for oncologists to select optimal therapy programs based on individual clinical attributes, and the Virtual Patient platform (OVP), which tailors drug regimens to patient populations and subpopulations using mathematical models to simulate and optimize treatment protocols. Optimata serves healthcare providers, pharmaceutical companies, and biotech firms, operating within the digital healthcare sector with a focus on medical decision support.

Company Intelligence Q&A

What is Optimata's primary focus?

Optimata focuses on personalized oncology treatment, developing solutions to predict patient prognoses and drug therapy benefits using advanced modeling and data integration.

What is PrediCare?

PrediCare is Optimata's decision support tool designed to assist oncologists in selecting optimal therapy programs by predicting patient responses to different regimens based on individual clinical attributes.

What is the Virtual Patient platform (OVP)?

The Virtual Patient platform (OVP) is Optimata's system that tailors drug regimens to patient populations and subpopulations. It utilizes mathematical models to simulate various treatment protocols and optimize schedules.

When did Optimata cease operations?

Optimata ceased to operate in December 2021.

Who founded Optimata?

Optimata was founded by Zvia Agur in January 2000.